Literature DB >> 6487489

The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man.

J A Clements, J A Critchley, L F Prescott.   

Abstract

The effects of paracetamol dose (5 and 20 mg/kg) and route of administration (intravenous and oral) on the urinary excretion of paracetamol and its glucuronide, sulphate, cysteine and mercapturic acid conjugates were studied in five healthy subjects. The fractional urinary excretion of unchanged paracetamol and its conjugates was independent of the route of administration at both dose levels, suggesting that the gastrointestinal tract is not an important site for paracetamol metabolism. The percentage of the dose excreted as the sulphate conjugate was significantly higher after 5 than after 20 mg/kg (37.7% and 33.3% respectively) and this is consistent with saturation of sulphate conjugation. No significant effect of paracetamol dose upon the area under the plasma concentration-time curve (AUC), corrected for dose, was found for the sulphate or glucuronide conjugates. The total plasma clearance of paracetamol and the renal clearance of the sulphate conjugate were significantly higher after the 5 than the 20 mg/kg dose (331 +/- 42 ml/min and 295 +/- 48 ml/min; 273 +/- 74 ml/min and 205 +/- 46 ml/min respectively). The oral systemic availability of paracetamol was 80% and independent of dose.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487489      PMCID: PMC1463596          DOI: 10.1111/j.1365-2125.1984.tb02495.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  The influence of the route of administration on urinary metabolites of isoetharine.

Authors:  F M Williams; R H Briant; C T Dollery; D S Davies
Journal:  Xenobiotica       Date:  1974-06       Impact factor: 1.908

2.  Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide.

Authors:  G Levy; H Yamada
Journal:  J Pharm Sci       Date:  1971-02       Impact factor: 3.534

3.  Metabolism of isoprenaline in the intestine.

Authors:  C F George; E W Blackwell; D S Davies
Journal:  J Pharm Pharmacol       Date:  1974-04       Impact factor: 3.765

4.  High performance liquid chromatographic estimation of paracetamol metabolites in plasma.

Authors:  P I Adriaenssens; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

5.  Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.

Authors:  M D Rawlins; D B Henderson; A R Hijab
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

6.  Metabolism of isoprenaline in dog and man.

Authors:  M E Conolly; D S Davies; C T Dollery; C D Morgan; J W Paterson; M Sandler
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

7.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

8.  Paracetamol disposition in normal subjects and in patients treated with antiepileptic drugs.

Authors:  E Perucca; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

9.  Determination of paracetamol and its metabolites in urine by high-performance liquid chromatography using ion-pair systems.

Authors:  J H Knox; J Jurand
Journal:  J Chromatogr       Date:  1978-02-11

Review 10.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

  10 in total
  36 in total

1.  Impaired absorption of paracetamol in vegetarians.

Authors:  L F Prescott; K Yoovathaworn; K Makarananda; R Saivises; K Sriwatanakul
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

2.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

3.  On the Molecular Basis Underlying the Metabolism of Tapentadol Through Sulfation.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

4.  Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients.

Authors:  Katie H Owens; Philip G M Murphy; Natalie J Medlicott; Julia Kennedy; Mathew Zacharias; Neil Curran; Sree Sreebhavan; Mark Thompson-Fawcett; David M Reith
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-05-21       Impact factor: 2.745

5.  Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.

Authors:  D J Morgan; J D Paull; B H Richmond; E Wilson-Evered; S P Ziccone
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

6.  The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 7.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

8.  The effect of acetaminophen administration on its disposition and body stores of sulphate.

Authors:  S Hendrix-Treacy; S M Wallace; K W Hindmarsh; G M Wyant; A Danilkewich
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.

Authors:  Angela Villiger; Cordula Stillhart; Neil Parrott; Martin Kuentz
Journal:  AAPS J       Date:  2016-04-08       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.